UBS Group
ANVS icon

UBS Group’s Annovis Bio ANVS Stock Holding History

UBS Group’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.9K Sell
11,775
-9,763
-45% -$19K ﹤0.01% 8106
2026
Q1 		$48K Sell
21,538
-9,105
-30% -$25K ﹤0.01% 7394
2025
Q4 		$106K Buy
30,643
+30,010
+4,741% +$90.2K ﹤0.01% 6883
2025
Q3 		$1.31K Sell
633
-25,684
-98% -$64.2K ﹤0.01% 9380
2025
Q2 		$57.1K Sell
26,317
-134,559
-84% -$266K ﹤0.01% 7671
2025
Q1 		$241K Buy
160,876
+112,140
+230% +$343K ﹤0.01% 6416
2024
Q4 		$245K Buy
48,736
+46,889
+2,539% +$339K ﹤0.01% 6328
2024
Q3 		$14.9K Sell
1,847
-11,143
-86% -$104K ﹤0.01% 7529
2024
Q2 		$74.8K Buy
12,990
+12,390
+2,065% +$100K ﹤0.01% 6381
2024
Q1 		$7.14K Hold
600
– – ﹤0.01% 7405
2023
Q4 		$11.2K Buy
600
+500
+500% +$4.43K ﹤0.01% 7401
2023
Q3 		$949 Hold
100
– – ﹤0.01% 8208
2023
Q2 		$1.43K Buy
+100
New +$1.42K ﹤0.01% 7924
2022
Q3 		– Sell
-414
Closed -$5K – 10296
2022
Q2 		$5K Buy
+414
New +$4.53K ﹤0.01% 8843
2022
Q1 		– Sell
-2,481
Closed -$44K – 10200
2021
Q4 		$44K Buy
2,481
+2,088
+531% +$53.8K ﹤0.01% 7026
2021
Q3 		$12K Sell
393
-775
-66% -$44.6K ﹤0.01% 7742
2021
Q2 		$100K Buy
+1,168
New +$54K ﹤0.01% 5875

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group's ANVS Position: Q2 2026 in Review

UBS Group reduced its Annovis Bio (ANVS) stake by 45% in Q2 2026, selling an estimated $19K and leaving 11,775 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #8106.

UBS Group first reported a position in ANVS in Q2 2021 and has held it in 17 quarters since. The position peaked at $245K in Q4 2024. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • UBS Group held 11,775 shares of Annovis Bio worth $21.9K as of Q2 2026.
  • UBS Group sold 9,763 Annovis Bio shares in Q2 2026, an estimated $19K.
  • Annovis Bio made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8106 holding.
  • UBS Group first reported a position in Annovis Bio in Q2 2021 and has held it in 17 quarters since.
  • UBS Group's Annovis Bio position peaked at $245K in Q4 2024.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.